Angel Arnaout

38.4k total citations · 1 hit paper
93 papers, 2.2k citations indexed

About

Angel Arnaout is a scholar working on Cancer Research, Oncology and Surgery. According to data from OpenAlex, Angel Arnaout has authored 93 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Cancer Research, 48 papers in Oncology and 26 papers in Surgery. Recurrent topics in Angel Arnaout's work include Breast Cancer Treatment Studies (59 papers), Breast Implant and Reconstruction (21 papers) and Global Cancer Incidence and Screening (19 papers). Angel Arnaout is often cited by papers focused on Breast Cancer Treatment Studies (59 papers), Breast Implant and Reconstruction (21 papers) and Global Cancer Incidence and Screening (19 papers). Angel Arnaout collaborates with scholars based in Canada, United States and United Kingdom. Angel Arnaout's co-authors include Muriel Brackstone, Frances C. Wright, Mark Clemons, Joyce M. Slingerland, Isabel Chu, Jun Sun, Jean-François Boileau, Sarkis Meterissian, Brigitte Poirier and Louis Gaboury and has published in prestigious journals such as Cell, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Angel Arnaout

92 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: The SN FNAC Study

2014 555 citations Jean-François Boileau, Angel Arnaout et al. profile →

Peers

Countries citing papers authored by Angel Arnaout

Since Specialization

Citations

This map shows the geographic impact of Angel Arnaout's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angel Arnaout with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angel Arnaout more than expected).

Fields of papers citing papers by Angel Arnaout

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angel Arnaout. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angel Arnaout. The network helps show where Angel Arnaout may publish in the future.

Co-authorship network of co-authors of Angel Arnaout

This figure shows the co-authorship network connecting the top 25 collaborators of Angel Arnaout. A scholar is included among the top collaborators of Angel Arnaout based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angel Arnaout. Angel Arnaout is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Shaping the future of healthcare in British Columbia: Establishing provincial clinical governance for responsible deployment of artificial intelligence tools 2024 ·Healthcare Management Forum ·Angel Arnaout, Paramjit Gill, Alice Virani, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sean Virani	1
2	Can routinely collected administrative data effectively be used to evaluate and validate endpoints used in breast cancer clinical trials? Protocol for a scoping review of the literature 2023 ·Systematic Reviews ·(unknown), Dianna Wolfe, Mark Clemons, (unknown), Kednapa Thavorn, Areti‐Angeliki Veroniki, Carole Lunny, Gregory R. Pond, Sharon F. McGee, Becky Skidmore, Angel Arnaout, Brian Hutton	1
3	Current Practices and Trends of Plastic and Oncoplastic Breast Surgeons in Canada 2023 ·Plastic Surgery ·(unknown), Emma Grigor, (unknown), Angel Arnaout, Jing Zhang	1
4	Outcomes of Immediate Breast Reconstruction in Triple Negative Breast Cancer: A Propensity Score-Matched Analysis 2022 ·Journal of Plastic Reconstructive & Aesthetic Surgery ·Emma Grigor, Michael J. Stein, Angel Arnaout, (unknown), Tim Ramsay, Jing Zhang	3
5	The Effect of Neoadjuvant Chemotherapy on Safety Outcomes Following Immediate Breast Reconstruction 2022 ·Journal of Plastic Reconstructive & Aesthetic Surgery ·Emma Grigor, Michael J. Stein, Angel Arnaout, (unknown), Tim Ramsay, Jing Zhang	4
6	Randomized trial of surveillance with abbreviated MRI in women with a personal history of breast cancer– impact on patient anxiety and cancer detection 2022 ·BMC Cancer ·(unknown), (unknown), (unknown), Diana Koszycki, (unknown), Roanne Segal, Angel Arnaout, Tim Ramsay, (unknown), Jean M. Seely	2
7	De-escalating adjuvant therapies in older patients with lower risk estrogen receptor-positive breast cancer treated with breast-conserving surgery: A systematic review and meta-analysis 2021 ·Cancer Treatment Reviews ·(unknown), Mark Clemons, Brian Hutton, (unknown), Jean-Michel Caudrelier, Lisa Vandermeer, (unknown), Deanna Saunders, (unknown), Carol Stober, (unknown), Risa Shorr, Angel Arnaout, Lynn Chang	9
8	Can we rely on surgical clips placed during oncoplastic breast surgery to accurately delineate the tumor bed for targeted breast radiotherapy? 2021 ·Breast Cancer Research and Treatment ·(unknown), Jean-Michel Caudrelier, Angel Arnaout, Lynn Chang, (unknown), (unknown), Jiheon Song, Jason Bélec, Eric Vandervoort	10
9	ASO Author Reflections: The Evolving Field of Oncoplastic Breast Conservation for the Management of Breast Cancer 2020 ·Annals of Surgical Oncology ·Michael J. Stein, Angel Arnaout, Jing Zhang	2
10	Assessing the effect of a hands-on oncoplastic surgery training course: A survey of Canadian surgeons 2020 ·Surgical Oncology ·Fernando A. Angarita, (unknown), Vanessa N. Palter, J. C. Richardson, Angel Arnaout, (unknown), (unknown), Muriel Brackstone, Fahima Osman	4
11	Patient Satisfaction Following Level II Oncoplastic Breast Surgery: A Comparison with Mastectomy Utililizing the Breast-Q Questionnaire will be published in Surgical Oncology 2020 ·Surgical Oncology ·(unknown), Laura Baker, William Petrcich, Jing Zhang, Angel Arnaout	18
12	Baseline Staging Imaging for Distant Metastasis in Women with Stages I, II, and III Breast Cancer 2020 ·Current Oncology ·Angel Arnaout, (unknown), (unknown), L. Grimard, (unknown), (unknown), Lisa Thain, Andrea Eisen	17
13	Quality-of-Life and Surgical Outcomes for Breast Cancer Patients Treated with Therapeutic Reduction Mammoplasty Versus Mastectomy with Immediate Reconstruction 2020 ·Annals of Surgical Oncology ·Michael J. Stein, (unknown), Angel Arnaout, Amanda Roberts, Erin Cordeiro, Tinghua Zhang, Jing Zhang	23
14	Paravertebral blocks in immediate breast reconstruction following mastectomy 2019 ·The Breast Journal ·Michael J. Stein, (unknown), (unknown), Patrick Wong, Angel Arnaout, Jing Zhang	7
15	How do the characteristics of breast cancer diagnostic assessment programmes influence service delivery: A mixed methods study 2017 ·European Journal of Cancer Care ·Anna R. Gagliardi, Gladys Honein‐AbouHaidar, (unknown), (unknown), Angel Arnaout, Jean M. Seely, Frances C. Wright, Mark Dobrow, Melissa Brouwers, Karina Bukhanov, David R. McCready	5
16	Both bulk and cancer stem cell subpopulations in triple‐negative breast cancer are susceptible to Wnt, HDAC, and ERα coinhibition 2016 ·FEBS Letters ·Andrew Sulaiman, (unknown), (unknown), (unknown), Carolyn Nessim, Angel Arnaout, Xuguang Li, Christina Addison, Jim Dimitroulakos, Lisheng Wang	28
17	Can the Referring Surgeon Enhance Accrual of Breast Cancer Patients to Medical and Radiation Oncology Trials? The Enhance Study 2016 ·Current Oncology ·Angel Arnaout, Iryna Kuchuk, Nathaniel Bouganim, Gregory R. Pond, S. Verma, Roanne Segal, Susan Dent, S. Gertler, (unknown), Femina Kanji, Mark Clemons	10
18	Surgical considerations in locally advanced breast cancer patients receiving neoadjuvant chemotherapy 2014 ·Current Opinion in Supportive and Palliative Care ·Angel Arnaout, Jean-François Boileau, Muriel Brackstone	13
19	Primary endocrine therapy as an approach for patients with localized breast cancer deemed not to be surgical candidates 2013 ·Current Opinion in Supportive and Palliative Care ·John Hilton, Angel Arnaout, Mark Clemons	8
20	Lymph Node Retrieval and Assessment in Stage II Colorectal Cancer: A Population-Based Study 2003 ·Annals of Surgical Oncology ·Frances C. Wright, Calvin Law, Linda Last, Mahmoud A. Khalifa, Angel Arnaout, (unknown), Neil Klar, Steve Gallinger, Andrew J. Smith	142

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact